We are live on ! Find out more
RNTX

Rein Therapeutics
RNTX

40 hedge funds and large institutions have $9.76M invested in Rein Therapeutics in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

11% more funds holding

Funds holding: 36 → 40 (+4)

6.38% more ownership

Funds ownership: 30.05% → 36.43% (+6.4%)

2% more capital invested

Capital invested by funds: $9.54M → $9.76M (+$217K)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
40
Holders Change
+4
Holders Change %
+11.11%
% of All Funds
0.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
7
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Voss Capital
Texas
+$1.57M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$361K
3
GS
Gagnon Securities
New York
+$199K
4
PM
Prosight Management
Texas
+$178K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$39.2K

Top Sellers

Rank Fund Capital Flow
1
SPC
Sigma Planning Corp
Michigan
-$29.1K
2
Citadel Advisors
Citadel Advisors
Florida
-$25.1K
3
UBS Group
UBS Group
Switzerland
-$19.8K
4
CPIG
Chicago Partners Investment Group
Illinois
-$12.9K
5
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$7.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$18.3K – – –
XT
27
XTX Topco
Cayman Islands
$17.2K +$19K +14,984 New
Cetera Investment Advisers
28
Cetera Investment Advisers
Illinois
$14.2K -$1.63K -1,282 -9%
WAM
29
Warberg Asset Management
Illinois
$12.6K +$14K +11,000 New
Mercer Global Advisors
30
Mercer Global Advisors
Colorado
$12K +$13.3K +10,461 New
GRP
31
Global Retirement Partners
California
$8.24K – – –
Rockefeller Capital Management
32
Rockefeller Capital Management
New York
$5.84K +$6.47K +5,097 New
TRCT
33
Tower Research Capital (TRC)
New York
$5.76K +$2.66K +2,098 +72%
JWA
34
JFS Wealth Advisors
Pennsylvania
$1.82K – – –
US Bancorp
35
US Bancorp
Minnesota
$1.43K – – –
Bank of America
36
Bank of America
North Carolina
$115 -$206 -162 -62%
UBS Group
37
UBS Group
Switzerland
$95 -$19.8K -15,618 -99%
Osaic Holdings
38
Osaic Holdings
Arizona
$40 – – –
BTI
39
Blue Trust Inc
Georgia
$23 – – –
Wells Fargo
40
Wells Fargo
California
– -$2.36K -1,688 Closed
Citigroup
41
Citigroup
New York
– -$1 -1 Closed
1
2

RNTX Hedge Fund Activity: Q3 2025 in Review

40 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Rein Therapeutics (RNTX) for Q3 2025, worth a combined $9.76M — up 2.3% from $9.54M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new RNTX positions and 2 closed out — a net gain of 4 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Voss Capital, adding an estimated $1.57M. The largest seller was Sigma Planning Corp, cutting an estimated $29.1K.

  • 40 institutional investors held Rein Therapeutics (RNTX) as of Q3 2025, up from 36 in Q2 2025.
  • Funds reported $9.76M of Rein Therapeutics stock for Q3 2025, up 2.3% quarter-over-quarter.
  • 6 funds opened new Rein Therapeutics positions in Q3 2025 and 2 closed out, a net change of +4 holders.
  • The largest Rein Therapeutics buyer in Q3 2025 was Voss Capital, an estimated $1.57M added.
  • The largest Rein Therapeutics seller in Q3 2025 was Sigma Planning Corp, an estimated $29.1K sold.

Based on aggregated 13F filings for Q3 2025.